BridgeMD
New treatment option for Cancer-associated Cachexia
Official title Visugromab in Cachexia International Trial
ClinicalTrials.gov ID: NCT07112196
What this study is testing
What is Visugromab (CTL-002)?
Visugromab (CTL-002) is an investigational medicine, being studied as a potential treatment for cancer-associated cachexia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: Does visugromab help participants put weight back on and have a better appetite?
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Weight loss
- Advanced cancer
You likely can't join if
- Participation in another treatment clinical trial, receipt of any investigational therapy or use of any investigational device within 4 weeks prior...
The study team makes the final eligibility decision.
Where it's taking place
- Norwich, Connecticut, United States
- Clermont, Florida, United States
- Orange City, Florida, United States
- East Brunswick, New Jersey, United States
- Avon, Ohio, United States
- Cleveland, Ohio, United States
- Fairview, Ohio, United States
- Mayfield Heights, Ohio, United States
- Haskovo, Bulgaria
- Plovdiv, Bulgaria
- Sofia, Bulgaria
- Vratsa, Bulgaria
- Hořovice, Czechia
- Hradec Králové, Czechia
- Prague, Czechia
- Brest, France
- Lyon, France
- Strasbourg, France
- Bonn, Germany
- Dresden, Germany
+ 30 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Norwich, Connecticut, United States; Clermont, Florida, United States; Orange City, Florida, United States; East Brunswick, New Jersey, United States; Avon, Ohio, United States; Cleveland, Ohio, United States and 44 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.